Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model

PaperCitations, authors & open-access status

Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 134 citations, 2011 year and closed oa status.

134
Citations
2011
Year
closed
OA Status

Related on ScholarIQ

Saturnino Spiga
Author
Neuroscience
Journal
Peroxisome Proliferator-Activated Receptors
Topic
Peroxisome Proliferator-Activated Receptors
Topic
Neuroinflammation and Neurodegeneration Mechanisms
Topic
Parkinson's Disease Mechanisms and Treatments
Topic
470M+ articles · free account